K E N N E T H I. D E N O S, P. C.

                                                    10757 SOUTH RIVER FRONT PKWY
                                                                       SUITE 125
                                                        SOUTH JORDAN, UTAH 84095
                                                                  (801) 816-2536
                                                             FAX: (801) 816-2599
                                                            JTHOMAS@DENOSLAW.COM

                                February 23, 2007

VIA FEDERAL EXPRESS
Mr. John L. Krug
Mr. Jeffrey Riedler
U.S. SECURITIES AND EXCHANGE COMMISSION
Division of Corporate Finance
100 F Street, NE, Mail Stop 6010
Washington, D.C. 20549
Telephone (202) 551-3862
Facsimile (202) 772-9217

          Re:  Cancer  Therapeutics,  Inc.
               Registration  Statement on Form 10SB
               File No. 0-52473

Dear Messrs. Krug and Riedler:

     This firm serves as counsel to Cancer Therapeutics, Inc. in connection with
its  submission of a  registration  statement  with the  Securities and Exchange
Commission  on Form 10 SB12G.  We  acknowledge  receipt of your  comments to our
initial filing on February 23, 2007. We thank you for your input and this letter
is  intended  to  respond  accordingly.  Each  paragraph  number of this  letter
corresponds to your comments to us dated February 23, 2007, and we have attached
two  redlined  copies and one clean copy,  each such copy bound,  of our amended
registration  statement  on Form SB-2 for your  timely  review  and  comment  as
appropriate.  We note to you that references to page numbers in the registration
statement will be with respect to the redlined copies.

GENERAL
-------

1. COMMENT.  Pursuant to section 12(g)(1) of the Exchange Act, your registration
statement will automatically  become effective 60 days after it was filed. If we
are not  finished  with  the  review  by that  time,  you  should  withdraw  the
registration statement and refile it to delay its effectiveness.

RESPONSE: Thank for your assistance with the process of arriving at an effective
date.


SIGNATURES TO FORM 10-SB
------------------------

2. COMMENT. The signature block currently refers to Secure Netwerks, Inc. Please
revise to  indicate  the  filing is signed on behalf of the  registrant,  Cancer
Therapeutics, Inc.

RESPONSE:  We have  corrected  this error on the  signature  page to reflect the
proper name, Cancer Therapeutics, Inc.

Please call me with any questions at (801) 816-2536 with any questions.

                                          Very truly yours,


                                          /s/ John D. Thomas
                                          -----------------------
                                          John D. Thomas


cc:   Robert Oldham, M.D.
      Michael Low
      Chene Gardner